Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
03/2002
03/20/2002CN1340344A Prescription of 'strong heart first-aid dropping pill' and its preparing process
03/20/2002CN1340343A Process for preparing buccal lozenge of low-hygroscopicity freeze-dried royal jelly powder
03/20/2002CN1340302A Nutritive health-care food for supplementing nucleic acid and its preparing process
03/20/2002CN1081071C Compounding method of bone morphogenesis protein to calcined bone
03/20/2002CN1081068C Traditional Chinese medicine for treating ischialogia neuralgia
03/20/2002CN1081066C Meidine for curing burn and scald and its preparation method
03/20/2002CN1081063C Fetus-protecting instant particles for treating habitual or threatened abortion
03/20/2002CN1081061C Medicinal pill for treating piles
03/20/2002CN1081060C Ointment for curing skin ulcer
03/20/2002CN1081059C Medicinal capsule for treating stomach-ache
03/20/2002CN1081056C Anticarcinogen injection and its preparing process
03/20/2002CN1081053C External use medicinal ointment for curing prolapse of lumbar intervertebral disc and preparing process thereof
03/20/2002CN1081052C Fast-acting piles-treating Chinese medicine preparation
03/20/2002CN1081051C Blood stasis removing analgesic plaster and its preparation
03/20/2002CN1081048C Method for preparing burn plaster
03/20/2002CN1081046C Medicinal decoction for treating diabets and its preparing process
03/20/2002CN1081045C Anti-cancer medicine composition and its preparing method
03/20/2002CN1081044C Medicine for treating cancer and preparing process thereof
03/20/2002CN1081043C Traditional Chinese medicine capsule 'Taibao' and its preparing process
03/20/2002CN1081042C Traditional Chinese medicinal composition for stopping drug taking and preparation process thereof
03/20/2002CN1081041C Medicine for treatment of malignant tumour and its prepn
03/20/2002CN1081040C Externally used medicine for treaitng frostbite and its preparation process
03/20/2002CN1081039C Cosmetic cream for curing comedo
03/20/2002CN1081021C Medicine deltoid belt for hernia
03/20/2002CN1081011C Health-care tonic canned food
03/20/2002CN1081010C Royal jelly lozenge
03/20/2002CN1080992C Process for extracting scorpion toxin
03/19/2002US6358917 Injection into depressor anguli oris muscle to cause paralysis; aging resistance
03/19/2002US6358741 Polynucleotide coding propagation regulator; for treating cell proliferative defects
03/19/2002US6358732 Nucleotide sequences preferential polypeptides for use in the treatment of defects in central nervous system
03/19/2002US6358727 Nucleotide sequences coding binding protein for use in treatment and prevention of infections
03/19/2002US6358704 M protein
03/19/2002US6358536 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal
03/19/2002US6358535 Method of treating herniated disks
03/19/2002US6358524 Target cell-specific non-viral vectors for inserting genes into cells, pharmaceutical compositions comprising such vectors and their use
03/19/2002US6358521 Fermented milk nutraceuticals
03/19/2002US6358507 Transgene expression systems
03/19/2002US6358506 Removing peripheral blood mononuclear cells (pbmc) from patient; treating said cells with a regulatory composition for a time sufficient to suppress said cells' aberrant immune responses; reintroducing cells to patient
03/19/2002CA2131316C A thrombin blood fraction for use in a medical procedure
03/19/2002CA1341348C Human tumor necrosis factor
03/18/2002CA2357685A1 Transfer factor composition and process for producing same
03/15/2002CA2357279A1 Composition for density gradient cell separation
03/14/2002WO2002020825A1 Method and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof
03/14/2002WO2002020822A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
03/14/2002WO2002020814A1 Self-rearranging dna vectors
03/14/2002WO2002020813A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
03/14/2002WO2002020769A1 Human and mouse targeting peptides identified by phage display
03/14/2002WO2002020762A2 Tnf receptor-like molecules and uses thereof
03/14/2002WO2002020724A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
03/14/2002WO2002020723A2 Compositions and methods for targeting peptides in humans in vivo
03/14/2002WO2002020722A2 Methods and compositions for in vitro targeting
03/14/2002WO2002020622A1 A mixture of non-sulfated fucose-based oligosaccharides, a cosmetic or pharmaceutical composition comprising said mixture and its use in cosmetics or pharmacy
03/14/2002WO2002020615A2 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders
03/14/2002WO2002020088A1 Method and system for myocardial infarction repair
03/14/2002WO2002020028A2 Method and composition for enhancing vision
03/14/2002WO2002019966A2 Cardiac arrhythmia treatment methods
03/14/2002WO2002019893A2 Improved cardiac function through administration of es cells
03/14/2002WO2002019832A1 MILK CONTAINING β-CASEIN WITH PROLINE AT POSITION 67 DOES NOT AGGRAVATE NEUROLOGICAL DISORDERS
03/14/2002WO2001079502A3 Vectors for gene therapy
03/14/2002WO2001077358A3 Herpes viruses for immune modulation
03/14/2002WO2001068226A3 A method of sorting cells
03/14/2002WO2001064046A3 Method for isolating sponge collagen and producing nanoparticulate collagen, and the use thereof
03/14/2002WO2001063286A3 Method for antigen-specific stimulation of t-lymphocytes with synthetic peptide libraries
03/14/2002WO2001051512A3 Human and parasite orphan receptor proteins
03/14/2002WO2001023001A3 Rapid peg-modification
03/14/2002WO2000065028A9 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR
03/14/2002WO2000050048A9 Bone marrow transplantation for hepatic regeneration and repair
03/14/2002US20020032915 Detecting size defect in animal infants; obtain tissue biopsy, monitor expression of somatomedins in sample, amplified somatomedin concentration indicates potential size defect in animals
03/14/2002US20020032488 Device for regeneration of articular cartilage and other tissue
03/14/2002US20020032326 Treating mammalian leukemia; lung carcinoma; colon adenocarcinoma malignant melanoma; assaying the human cytochrome CYP3A4 metabolism of ecteinascidin 743
03/14/2002US20020032163 Administering to subject a high dosage of an inactivated virus prior to administration of of a live recombinant virus carrying a transgene
03/14/2002US20020032157 Methods of inhibiting ectopic calcification
03/14/2002US20020032152 Anti-helicobacter vaccine complex
03/14/2002US20020031831 Plasmid for use in vaccination and gene therapy
03/14/2002US20020031824 Preferential migration of and association of progenitor cells; obtain cells, administer cells to human, detect preferential binding
03/14/2002US20020031823 Use of trans-activation and CIS-activation to modulate the persistence of expression of a transgene
03/14/2002US20020031792 Complexing with monoclonal antibodies
03/14/2002US20020031787 Detecting autoimmune disease; obtain blood sample, measure amount of lymphocytes in blood, diagnose autoimmune disease
03/14/2002US20020031757 Generation of preferential cells; obtain cell sample, propagate cells, recover cells
03/14/2002US20020031563 Plant extracts
03/14/2002US20020031554 Asthma therapy; dietetic nutrient
03/14/2002US20020031530 In ovo vaccination against coccidiosis
03/14/2002US20020031529 Neurotoxin therapy for diabetes
03/14/2002US20020031528 Vaccines containing beta-hexosamine bind with antibodies and carriers
03/14/2002US20020031527 Bulking agents, cryoprotectants and lyoprotectants added for storage stability
03/14/2002US20020031509 Pharmaceutical composition and method for its manufacture
03/14/2002US20020031507 Treatment of inflammatory processes of the intestine, hypercholesterolaemia and infections with Helicobacter pylori; anticarcinogenic agent
03/14/2002US20020031503 Lactobacillus rhamnosus HN001 and HN 067, Lactobacillus acidophilus HN017, and Bifidobacterium lactis HN019
03/14/2002US20020031501 Cardiomyocytes for heart muscles damaged in heart attacks
03/14/2002US20020031500 Delivery of therapeutic biologicals from implantable tissue matrices
03/14/2002US20020031499 Defective recombinant adenoviruses expressing cytokines for antitumor treatment
03/14/2002US20020031498 Culturing lineage committed human cells under liquid culture conditions, including replacement of liquid culture medium at a rate and for a time sufficient to obtain human lineage committed cells; skin, bone marrow replacements, therapy
03/14/2002US20020031497 Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases
03/14/2002DE10106321A1 Mud bath mass used for medicinal-balneological applications comprises bath peat and fuller's earth
03/14/2002DE10043982A1 Verfahren zur Verbesserung des Haarwuchses menschlichen Kopfhaares A method for improving hair growth of human head hair
03/14/2002DE10041515A1 Verfahren zur Herstellung gebrauchsfertiger, Antigen-beladener oder -unbeladener, kryokonservierter reifer dendritischer Zellen Process for the production of ready, antigen-loaded or -unbeladener, cryopreserved mature dendritic cells
03/14/2002CA2421842A1 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders
03/14/2002CA2421584A1 Gene therapy for cardiac arrythmias
03/14/2002CA2421451A1 Method and system for myocardial infarction repair
03/14/2002CA2421380A1 Biopanning and rapid analysis of selective interactive ligands (brasil)